bioMerieux
100 Rodolphe Street
Durham
North Carolina
27712
United States
Tel: (800) 682-2666
Website: http://www.biomerieux-usa.com/
About bioMerieux
World leader in the field of in vitro diagnostics for over 55 years, bioMérieux conceives, develops, produces and markets diagnostics solutions (systems, reagents, software and services) intended for clinical and industrial applications, which determine the origin of a disease or a contamination to improve the health of patients and insure consumer safety.
bioMérieux is present in 43 countries and servces more than 160 countries with the support of a large network of distributors. Its corporate headquarters are located in Marcy l'Etoile, near Lyon, in France.
Joining bioMérieux, is choosing to join an innovative company with a long term vision, committed to the service of public health and carried out with a humanistic corporate culture.
We look for candidates whose motivation is to invest in themselves, in the projects of the future, and to participate in a collective adventure led by a pioneering spirit.
We have the commitment to offer our collaborators a working environment which encourages team spirit, with priority given to training and development with international career opportunities.
Our Group offers numerous possibilities: so come and join the 11,200 bioMérieux employees who have already identified with these values!
75 articles about bioMerieux
-
bioMerieux, Inc. Recognized By Frost & Sullivan For Market Leadership In In Vitro Diagnostics For Clinical And Industrial Applications
7/27/2006
-
bioMerieux, Inc. Releases Two New Real-Time NASBA® Analyte Specific Reagents For Mycoplasma pneumoniae And Chlamydophila (Chlamydia) Pneumoniae
7/25/2006
-
Bio-Rad Laboratories, Inc. And bioMerieux, Inc. Reach Settlement Of Licensing Disputes
7/18/2006
-
Trinity Biotech Completes Acquisition Of Coagulation Product Line Of bioMérieux
6/27/2006
-
The Day In Review: Encysive Pharmaceuticals Re-Submits Thelin
5/25/2006
-
bioMerieux, Inc. Receives The 2006 Frost & Sullivan Award For Technology Innovation For Developing The NucliSens(R) EasyMAG(TM) Platform
4/25/2006
-
bioMérieux Seeks Creative Work From College Students In North Carolina And Missouri For "Innovation in Art" Contest
3/29/2006
-
ExonHit Therapeutics SA And bioMerieux, Inc. Reach An Important Research Milestone In The Molecular Detection Of Breast Cancer From Blood Samples
3/28/2006
-
bioMerieux, Inc. Announces 2005 Financial Results
3/20/2006
-
bioMerieux, Inc. Launches An Avian Flu Test For Research Purposes
2/7/2006
-
Primagen Holding B.V. Licenses Newly Discovered Coronavirus CoV-NL63 To bioMerieux, Inc.
2/1/2006
-
bioMerieux, Inc. Exercises Second Option To License RNA Technology From Gen-Probe Incorporated
12/22/2005
-
bioMérieux Appoints New Senior Vice President At North American Headquarters
10/26/2005
-
Open Text Release: Life Sciences Companies Quickly Turning To ECM Software To Manage Compliance
2/1/2005
-
bioMerieux Launches Intelligent Patient Therapy Management Solution
12/10/2004